Neuralink Overview

  • Founded
  • 2016
Founded
  • Status
  • Private
  • Employees
  • 217
Employees
  • Latest Deal Type
  • Series C
  • Latest Deal Amount
  • $205M
Latest Deal Amount
  • Investors
  • 16

Neuralink General Information

Description

Developer of an implantable brain-machine interface designed to help people with paralysis. The company's interface is designed to treat and diagnose neurological conditions in humans and conceivably augment human cognitive powers, enabling doctors to treat serious brain diseases in the short term.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 7400 Paseo Padre Parkway
  • Fremont, CA 94555
  • United States
+1 (650) 000-0000

Neuralink Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Neuralink Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series C) 30-Jul-2021 $205M 00000 00.00 Completed Generating Revenue
2. Early Stage VC 28-Jun-2019 0000 00000 00000 Completed Generating Revenue
1. Early Stage VC 24-Aug-2017 $107M $107M 00000 Completed Generating Revenue
To view Neuralink’s complete valuation and funding history, request access »

Neuralink Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 00,000,000 00.000000 00.00 000.00 000.00 00 000.00 0.000
Series B-1 00,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series B 13,391,700 $0.001000 $0.19 $3.82 $3.82 1x $3.82 8.74%
Series A 107,000,000 $0.001000 $0.05 $1 $1 1x $1 69.84%
To view Neuralink’s complete cap table history, request access »

Neuralink Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of an implantable brain-machine interface designed to help people with paralysis. The company's interface is d
Therapeutic Devices
Fremont, CA
217 As of 2022
00000
0.00 0000-00-00
00000000000 00000

00000000

quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure
00000 0000000000 0000000000 0000000
Providence, RI
0000000000

00000000

o eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud
00000 0000000000 0000000000 0000000
Austin, TX
00 As of 0000
000.00
00.00 0000-00-00
000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Neuralink Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BrainGate Angel-Backed Providence, RI 0000000000
00000000000 Venture Capital-Backed Austin, TX 00 000.00 000000000 000.00
00000000 Venture Capital-Backed Mountain View, CA 000 00000 00000000000 00000
00000000 Venture Capital-Backed Pompano Beach, FL 000 00000 00000000000 00000
000000000 Venture Capital-Backed Santa Clara, CA 00 000.00 000000000 - 000.00
You’re viewing 5 of 8 competitors. Get the full list »

Neuralink Patents

Neuralink Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210012909-A1 Real-time neural spike detection Pending 12-Jul-2019 000000000
US-20210007602-A1 Brain implant with subcutaneous wireless relay and external wearable communication and power device Pending 12-Jul-2019 0000000000
US-20210007808-A1 Optical coherence tomography for robotic brain surgery Pending 12-Jul-2019 000000000
US-11107703-B2 Monolithic, biocompatible feedthrough for hermetically sealed electronics and methods of manufacture Active 12-Jul-2019 000000000 00
US-20210013051-A1 Monolithic, biocompatible feedthrough for hermetically sealed electronics and methods of manufacture Granted 12-Jul-2019 H01B7/08
To view Neuralink’s complete patent history, request access »

Neuralink Executive Team (10)

Name Title Board Seat Contact Info
Dongjin Seo Vice President of Implant & Founding Member
Paul Merolla Ph.D Co-Founder
Shivon Zilis Project Director, Office of the CEO
Jared Birchall Co-Chief Executive Officer, Chief Financial Officer & President
Elon Musk Co-Founder & Co-Chief Executive Officer
You’re viewing 5 of 10 executive team members. Get the full list »

Neuralink Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neuralink Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Blake Byers Angel (individual) Minority 000 0000 000000 0
EXOR Seeds Venture Capital Minority 000 0000 000000 0
Founders Fund Venture Capital Minority 000 0000 000000 0
Fred Ehrsam Angel (individual) Minority 000 0000 000000 0
GigaFund Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 16 investors. Get the full list »